Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 670 Records) |
Query Trace: Neoplasms and CHEK2[original query] |
---|
Association of Moderate-Risk Breast Cancer Genes with Contralateral Prophylactic Mastectomy and Bilateral Disease. Annals of surgical oncology 2023 9 . Jennifer Q Zhang, Carlos Henrique Dos Anjos, Varadan Sevilimedu, Angelena Crown, Kimberly A Amoroso, Melissa L Pilewskie, Mark E Robson, Mary L Gemigna |
Impact of High-to-Moderate Penetrance Genes on Genetic Testing: Looking over Breast Cancer. Genes 2023 8 14 (8): . Antonella Turchiano, Marilidia Piglionica, Stefania Martino, Rosanna Bagnulo, Antonella Garganese, Annunziata De Luisi, Stefania Chirulli, Matteo Iacoviello, Michele Stasi, Ornella Tabaku, Eleonora Meneleo, Martina Capurso, Silvia Crocetta, Simone Lattarulo, Yevheniia Krylovska, Patrizia Lastella, Cinzia Forleo, Alessandro Stella, Nenad Bukvic, Cristiano Simone, Nicoletta Res |
Frequency of germline pathogenic variants in breast cancer predisposition genes among young Turkish breast cancer patients. Breast cancer research and treatment 2023 8 . Aysun Dauti Isiklar, Lamiya Aliyeva, Ahmet Yesilyurt, Aykut Soyder, Gul Basar |
Next generation sequencing reveals a high prevalence of pathogenic mutations in homologous recombination DNA damage repair genes among patients with uterine sarcoma. Gynecologic oncology 2023 8 177 14-19. Dimitrios Nasioudis, Nawar A Latif, Emily M Ko, Lori Cory, Sarah H Kim, Lainie Martin, Fiona Simpkins, Robert Giunto |
Breast cancers in monoallelic MUTYH germline mutation carriers have clinicopathological features overlapping with those in BRCA1 germline mutation carriers. Breast cancer research and treatment 2023 12 . Aysenur Keske, Paul Weisman, Monica Ospina-Romero, Prachi Raut, Kelcy Smith-Simmer, Anna L Zakas, Christopher Flynn, Jin |
Profiling of the genetic features of patients with breast, ovarian, colorectal and extracolonic cancers: Association to CHEK2 and PALB2 germline mutations. Clinica chimica acta; international journal of clinical chemistry 2023 12 552 117695. Mar Infante, Mónica Arranz-Ledo, Enrique Lastra, Amaya Olaverri, Raquel Ferreira, Marta Orozco, Lara Hernández, Noemí Martínez, Mercedes Dur |
Germline mutations in pediatric cancer cohort with mixed-ancestry Mexicans. Molecular genetics & genomic medicine 2023 12 e2332. Oscar Alonso-Luna, Gabriela E Mercado-Celis, Jorge Melendez-Zajgla, Rodrigo Barquera, Marta Zapata-Tarres, Luis Enrique Juárez-Villegas, Elvia Cristina Mendoza-Caamal, Elianeth Rey-Helo, Socorro Aida Borges-Yañ |
Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants. Breast cancer research and treatment 2023 12 . Christopher J Schwartz, Nikka Khorsandi, Amie Blanco, Rita A Mukhtar, Yunn-Yi Chen, Gregor Krin |
PTPN13 rs989902 and CHEK2 rs738722 are associated with esophageal cancer. Annals of medicine 2023 12 55 (2): 2281659. Ruisha Tu, Dunjing Zhong, Ping Li, Yongyu Li, Zhuang Chen, Feixiang Hu, Guihong Yuan, Zhaowei Chen, Shuyong Yu, Jian So |
The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families. Breast (Edinburgh, Scotland) 2023 12 73 103611. Maartje A C Schreurs, Teresa Ramón Y Cajal, Muriel A Adank, J Margriet Collée, Antoinette Hollestelle, Jeroen van Rooij, Marjanka K Schmidt, Maartje J Hooni |
Impact of germline DNA repair gene variants on prognosis and treatment of men with advanced prostate cancer. Scientific reports 2023 11 13 (1): 19135. Emma B Hansen, Questa Karlsson, Susan Merson, Sarah Wakerell, Reshma Rageevakumar, Jørgen B Jensen, Michael Borre, Zsofia Kote-Jarai, Rosalind A Eeles, Karina D Sørens |
Exome Sequencing Reveals Novel Germline Variants in Breast Cancer Patients in the Southernmost Region of Thailand. Journal of personalized medicine 2023 11 13 (11): . Panupong Sukpan, Surasak Sangkhathat, Hutcha Sriplung, Wison Laochareonsuk, Pongsakorn Choochuen, Nasuha Auseng, Weerawan Khoonjan, Rusta Salaeh, Kornchanok Thangnaphadol, Kasemsun Wanawanakorn, Kanyanatt Kanokwiro |
Detection Rate and Spectrum of Pathogenic Variations in a Cohort of 83 Patients with Suspected Hereditary Risk of Kidney Cancer. Genes 2023 11 14 (11): . Zangbéwendé Guy Ouedraogo, Florian Ceruti, Mathis Lepage, Mathilde Gay-Bellile, Nancy Uhrhammer, Flora Ponelle-Chachuat, Yannick Bidet, Maud Privat, Mathias Cavail |
Further Association of Germline CHEK2 Loss-of-Function Variants with Testicular Germ Cell Tumors. Journal of clinical medicine 2023 11 12 (22): . Kira Kirchner, Christoph Seidel, Finn-Ole Paulsen, Bianca Sievers, Carsten Bokemeyer, Davor Less |
Spectrum of histopathologic findings in risk-reducing bilateral prophylactic mastectomy in patients with and without BRCA mutations. Human pathology 2023 11 . Baris Boyraz, Amy |
Rate of Pathogenic Germline Variants in Patients With Lung Cancer. JCO precision oncology 2023 11 7 e2300190. Steven Sorscher, Jaclyn LoPiccolo, Brandie Heald, Elaine Chen, Sara L Bristow, Scott T Michalski, Sarah M Nielsen, Alix Lacoste, Emil Keyder, Hayan Lee, Robert L Nussbaum, Renato Martins, Edward D Espl |
Multi-gene panel testing and association analysis in Cypriot breast cancer cases and controls. Frontiers in genetics 2023 10 14 1248492. Maria Zanti, Maria A Loizidou, Denise G O'Mahony, Leila Dorling, Joe Dennis, Peter Devilee, Douglas F Easton, Mihalis I Panayiotidis, Andreas Hadjisavvas, Kyriaki Michailid |
Genomic ancestry in kidney cancer: Correlations with clinical and molecular features. Cancer 2023 10 . Ritesh R Kotecha, Andrea Knezevic, Kanika Arora, Chaitanya Bandlamudi, Fengshen Kuo, Maria I Carlo, Kelly N Fitzgerald, Darren R Feldman, Neil J Shah, Ed Reznik, A Ari Hakimi, Jian Carrot-Zhang, Diana Mandelker, Michael Berger, Chung-Han Lee, Robert J Motzer, Martin H Vo |
Hereditary cancer testing in a diverse sample across three breast imaging centers. Breast cancer research and treatment 2023 10 . Laura Westbrook, Darlene Miltenburg, Vivienne Souter, Melissa K Maisenbacher, Katherine L Howard, Youbao Sha, Maygol Yavari, Nicholas Kypraios, Angel Rodriguez, Jeffrey N Weitz |
Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study. ESMO open 2023 10 8 (6): 102041. S Joris, H Denys, J Collignon, M Rasschaert, D T'Kint de Roodenbeke, F P Duhoux, J-L Canon, S Tejpar, J Mebis, L Decoster, P Aftimos, J De Grè |
Breast and colorectal cancer risks among over 6,000 CHEK2 pathogenic variant carriers: A comparison of missense versus truncating variants. Cancer genetics 2023 10 278-279 84-90. Erin Mundt, Brent Mabey, Irene Rainville, Charite Ricker, Nanda Singh, Anna Gardiner, Susan Manley, Thomas Slav |
Genetic contribution of breast cancer genes in women of black African origin. Frontiers in genetics 2024 1 14 1302645. Rokhaya Ndiaye, Jean Pascal Demba Diop, Ahmadou Dem, Alioune Die |
Molecular and clinicopathological features of KIT/PDGFRA wild-type gastrointestinal stromal tumors. Cancer science 2024 1 . Toshirou Nishida, Yoichi Naito, Tsuyoshi Takahashi, Takuro Saito, Shigeo Hisamori, Dai Manaka, Katsuhiro Ogawa, Seiichi Hirota, Hitoshi Ichika |
CHEK2 founder variants and thyroid cancer risk. Thyroid : official journal of the American Thyroid Association 2024 1 . Pamela Brock, Sandya Liyanarachchi, Taina Tuulikki Nieminen, Carlos Chan, Wendy Kohlmann, Leigh Anne Stout, Song Yao, Amanda La Greca, Kirk E Jensen, Jill Kolesar, Bodour Salhia, Pat Gulhati, J Kevin Hicks, Matthew D Ring |
Histologic patterns in prostatic adenocarcinoma are not predictive of mutations in the homologous recombination repair pathway. Human pathology 2024 1 . Jon Mahlow, Marc Barry, Daniel J Albertson, Yeon Jung Jo, Michael Balatico, Tori Seasor, Georges Gebrael, Shruti A Kumar, Nicolas Sayegh, Nishita Tripathi, Neeraj Agarwal, Umang Swami, Deepika Siro |
Upgrade Rates and Breast Cancer Development Among Germline Pathogenic Variant Carriers with High-Risk Breast Lesions. Annals of surgical oncology 2024 1 . Alison Laws, Saskia Leonard, Emma Hershey, Samantha Stokes, Julie Vincuilla, Eshita Sharma, Kara Milliron, Judy E Garber, Sofia D Merajver, Tari A King, Melissa L Pilewsk |
Germline DNA Damage Response Gene Mutations in Localized Prostate Cancer. Medicina (Kaunas, Lithuania) 2024 1 60 (1): . Tomas Januskevicius, Ieva Vaicekauskaite, Rasa Sabaliauskaite, Augustinas Matulevicius, Alvydas Vezelis, Albertas Ulys, Sonata Jarmalaite, Feliksas Jankevici |
Genetic predisposition to differentiated thyroid cancer among Polish population. Polish archives of internal medicine 2024 1 . Martyna Borowczyk, Mateusz Sypniewski, Joanna Szyda, Ma?gorzata Braszka, Katarzyna Ziemnicka, Marek Rucha?a, Michalina Oszywa, Zbigniew J Król, Paula Dobo |
Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing. Pathology, research and practice 2024 1 254 155075. Seref Bugra Tuncer, Betul Celik, Seda Kilic Erciyas, Ozge Sukruoglu Erdogan, Busra Kurt Gültaslar, Demet Akdeniz Odemis, Mukaddes Avsar, Fatma Sen, P?nar Mualla Saip, Hulya Yazi |
Checkpoint Kinase 2 (CHEK2) Gene Mutation in a Patient With Breast and Prostate Cancer: A Unique Presentation of a Rare Disease. Cureus 2024 1 15 (11): e49710. Samar N Ekram, Nasser Al Shanbari, Bassam M Bin Laswad, Abdulrahman Alharthi, Waseem Tayeb, Abdulbari Bah |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: